ARMS(redirected from APSAC Reocclusion Multicentre Study)
Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia.
ARMSAPSAC Reocclusion Multicentre Study. A trial assessing the effect of anisoylated plasminogen streptokinase activator complex (APSAC, or anistreplase) on coronary artery patency post AMI.
Conclusion At 90 min, 73% had patent infarct-related vessels; at 24 h, 96%; at 2 months, 11.5% reinfarcted.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.